http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105646398-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-135
filingDate 2014-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105646398-B
titleOfInvention Preparation method of N-((1R,4R)-4-(4-(cyclopropylmethyl)piperazin-1-yl)cyclohexyl)acetamide
abstract The invention discloses a preparation method of N-((1R,4R)-4-(4-(cyclopropylmethyl)piperazin-1-yl)cyclohexyl)acetamide, comprising the following steps: (1) The compound shown in the structural formula (2) and the compound shown in the formula (3) are reacted in the presence of the catalyst tetraisopropyl titanate in a solvent; (2) then adding an alcoholic solvent and a reducing agent, and reacting at room temperature (time B), then collect described N-((1R,4R)-4-(4-(cyclopropylmethyl) piperazin-1-yl) cyclohexyl) acetamide from the reaction product; the present invention It is a "one-pot" reaction, the product is the target product 4, the yield is high, and the reaction is controllable. A large number of experiments have proved that only when tetraisopropyl titanate/alcohol/reducing agent exist at the same time to carry out the "one pot" reaction, can the product 4 be obtained in high yield; the advantages of the present invention are: the raw materials are easy to obtain, the conditions are mild, The post-treatment is simple, the target product can be obtained in high yield, and is suitable for large-scale industrial production.
priorityDate 2014-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009153197-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101023070-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010280037-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103168040-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID110612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20587905
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID178
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11400745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4311764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10461508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451404211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447816241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454306093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22959485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592133
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447535447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836

Total number of triples: 47.